Loading organizations...
Loading organizations...
Cellular immunotherapy company integrating innate and adaptive programs.
Cero Therapeutics has raised $40.0M across 1 funding round.
Cero Therapeutics has raised $40.0M in total across 1 funding round.
Cero Therapeutics has raised $40.0M in total across 1 funding round.
Cero Therapeutics's investors include Altitude Life Science Ventures, Robert Nelsen, Hongshan Capital Group (Sequoia Capital China), Richard Klausner, Milky Way Investments.
Cero Therapeutics has raised $40.0M across 1 funding round. Most recently, it raised $40.0M Series A in March 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 18, 2020 | $40.0M Series A | Altitude Life Science Ventures, Robert Nelsen, Hongshan Capital Group (Sequoia Capital China), Richard Klausner, Milky Way Investments |